Relief from the itch in atopic dermatitisAn experimental drug designed to control itching in people with moderate-to-severe AD shows promise in early trial.
Gene mutation identified in atopic dermatitisA new study shows that mutations in the gene CARD11 are associated with severe atopic disease.
New psoriasis patient profileMetabolomics could provide new statistical methods to help monitor psoriasis disease and progression.
Biologic risk tolerance differs for pregnant patientsOf several biologic agents that women of reproductive age can choose from to treat and manage psoriasis, not all have the same safety profile during pregnancy and lactation periods.
House dust mites and severe atopic dermatitis: A new connectionPatients with severe atopic dermatitis who have lower serum vitamin D levels have a high sensitivity to house dust mites which can aggravate their condition, a new study shows.
IL-31 pathway may lead to new treatments for pruritusIn early research, subcutaneous nemolizumab significantly reduced pruritus in moderate-to-severe atopic dermatitis adult patients.
August clinical considerations for NPs and PAsIn this month’s Clinical Considerations, we learn from a new study that laser treatment following isotretinoin therapy can possibly be initiated sooner than we thought; researchers have shown microwave technology may reduce underarm odor, and glean guidance for diagnosing mycosis fungoides.
Expense drivers for costliest psoriasis patientsFindings of a recent study challenge the notion that psoriasis patients may be generally healthy and only acquire expenses related to their medications or psoriasis.
Dermatologists collaborate on data-driven pediatric psoriasis researchA global community of physicians cooperated to share experiences with systemic drugs for pediatric psoriasis, and to get experience with a joint registry. A uniform dataset could be tapped to learn more about disease manifestations and treatment outcomes
Sulzberger lecturer provides in-depth look at psoriasis comorbiditiesIn his talk at AAD 2017, Joel M. Gelfand, MD, MSCE, discussed the findings from research investigating associations between psoriasis and comorbidities and their relevance for providing comprehensive medical care for patients with psoriasis.


View Results